You are living through one of the most difficult moments a family can face. You have been told your father's pancreatic cancer is not responding to the standard

You have just learned the pancreatic cancer has spread, and the term "chemotherapy" hangs in the air like a verdict from another decade.

The imaging report is back, and the words you dreaded are there: recurrence. Pancreatic cancer is notoriously relentless.

The scan report confirms pancreatic cancer. The surgeon shakes his head. Surgery is off the table.

Stage 4 pancreatic cancer treatment centers on combination chemotherapy (FOLFIRINOX, gemcitabine/nab-paclitaxel), single-agent regimens, targeted therapies for actionable mutations, and thorough palliative care, selected primarily by performance status (ECOG 0-1 vs. 2 vs. 3-4) and treatment goals (life extension vs. Quality of life). Key Takeaways FOLFIRINOX and gemcitabine/nab-paclitaxel serve as first-line chemotherapy options, selected by ECOG performance status, age, and